Skip to main content

Advertisement

Log in

Influence of Heparanase and VEGF-C mRNA Expressions in Lung Cancer

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

The objective of this study is to investigate relationship between the expressions of heparanase and vascular endothelial growth factor-C (VEGF-C) mRNA and tumorigenesis, progression in human lung cancer. The expressions of heparanase and VEGF-C mRNA in 65 cases of lung cancer (31 cases of squamous cell carcinoma, 25 adenocarcinoma, 3 large cell carcinoma, and 6 small cell carcinoma), adjacent tissues of cancer, and normal tissues were tested by reverse transcription-polymerase chain reaction (RT-PCR) and analyzed by clinico-pathological characteristics and prognosis of lung cancer. The rate of expressions of heparanase and VEGF-C mRNA in tumor tissues (55.4, 61.5 %) was significantly higher than that in adjacent tissues of cancer (12.3, 15.4 %) and normal tissues (3.1, 4.6 %) (P < 0.05). It was shown that heparanase and VEGF-C mRNA expressions did not correlate with the pathological type and grade of the tumor (P > 0.05), but they correlated with the clinical stage and survival time of the patients (P < 0.05). Overexpression of heparanase and VEGF-C mRNA in lung cancer tissues perhaps participates in regulation of tumorigenesis and progression. The expressions of heparanase and VEGF-C mRNA should be used as a useful marker of the biological behavior of lung cancer and as an independent prognosis factor for the patient’s survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig 1
Fig 2

Similar content being viewed by others

References

  1. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I (1999) Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 5:793–802

    Article  CAS  PubMed  Google Scholar 

  2. Vlodavsky I, Friedmann Y (2001) Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 108:341–347

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Benke EM, Ji Y, Patel V, Wang H, Miyazaki H, Yeudall WA (2010) VEGF-C contributes to head and neck squamous cell carcinoma growth and motility. Oral Oncol 46:19–24

    Article  Google Scholar 

  4. Watanabe M, Aoki Y, Kase H, Tanaka K (2003) Heparanase expression and angiogenesis in endometrial cancer. Gynecol Obstet Investig 56:77–82

    Article  CAS  Google Scholar 

  5. Shafat I, Pode D, Peretz T, Ilan N, Vlodavsky I, Nisman B (2008) Clinical significance of urine heparanase in bladder cancer progression. Neoplasia 10:125–130

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Nobuhisa T, Naomoto Y, Ohkawa T, Takaoka M, Ono R, Murata T, Gunduz M, Shirakawa Y, Yamatsuji T, Haisa M, Matsuoka J, Tsujigiwa H, Nagatsuka H, Nakajima M, Tanaka N (2005) Heparanase expression correlates with malignant potential in human colon cancer. J Cancer Res Clin Oncol 131:229–237

    Article  CAS  PubMed  Google Scholar 

  7. Quiros RM, Rao G, Plate J, Harris JE, Brunn GJ, Platt JL, Gattuso P, Prinz RA, Xu X (2006) Elevated serum heparanase-l levels in patients with pancreatic carcinoma are associated with poor surviva1. Cancer 106:532–540

    Article  CAS  PubMed  Google Scholar 

  8. Peng C, Sun Q, Fang Y, Cong B, Zhao X (2011) VEGF-C antisense oligoxydeonucleotide suppression of invasive ability of the A-549 lung carcinoma cell line. Asian Pac J Cancer Prev 12:2097–2099

    PubMed  Google Scholar 

  9. Cohen-Kaplan V, Naroditsky I, Zetser A, Ilan N, Vlodavsky I, Doweck I (2008) Heparanase induces VEGF-C and facilitates tumor lymphangiogenesis. Int J Cancer 123:2566–2573

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Zhang Q, Ming J, Li Y, Zhang S, Li B, Qiu X, Wang E (2009) Heparanase expression correlates with angiogenesis and lymphangiogenesis in human lung cancer. Zhongguo Fei Ai Za Zhi 12:867–868

    Google Scholar 

Download references

Acknowledgments

The authors wish to thank Tian Hui (of the Thoracic Department of Qilu Hospital) for his continued support and major contributions to this research work. The authors also wish to express special thanks to Guo Jiazhong (Division of Thoracic Surgery, Shandong University) for data management and outstanding technical assistance. Regarding funding, this piece of his research was supported by the Science and Technology Agency of Shandong Province, the People’s Republic of China.

Conflict of Interest

The authors declare that they have no competing interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chuanliang Peng.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Maimaitiyiming, X., Jin, C. et al. Influence of Heparanase and VEGF-C mRNA Expressions in Lung Cancer. Indian J Surg 77, 477–480 (2015). https://doi.org/10.1007/s12262-015-1291-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-015-1291-y

Keywords

Navigation